Oxadiazole beta carboline derivatives as antidiabetic compounds

Details for Australian Patent Application No. 2010204912 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Du, Wu; Hagmann, William K.; He, Shuwen; Lai, Zhong; Shah, Shrenik K.; Truong, Quang T.

Agent Spruson & Ferguson

Pub. Number AU-A-2010204912

PCT Pub. Number WO2010/083136

Priority 61/205,451 16.01.09 US

Filing date 12 January 2010

Wipo publication date 22 July 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/437 (2006.01)

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/083136 Priority application(s): WO2010/083136

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010204915-Container for depilatory composition

2010204911-Aspirated wound dressing